What causes an elevated Insulin-like Growth Factor-1 (IGF-1) level in a 71-year-old female?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of IGF-1 Level of 183 ng/mL in a 71-Year-Old Female

An IGF-1 level of 183 ng/mL in a 71-year-old female is most likely normal for age, as IGF-1 physiologically declines with aging and this value typically falls within the reference range for this demographic. However, if this represents an elevation above age-matched norms, the primary pathological concern is acromegaly from a GH-secreting pituitary adenoma, which requires confirmation with serum growth hormone measurement and pituitary imaging 1.

Age-Appropriate Interpretation

  • IGF-1 must be interpreted against age-matched, sex-matched reference ranges because levels decline substantially with aging 1
  • For a 71-year-old woman, an IGF-1 of 183 ng/mL typically falls within normal limits for most laboratory assays 1
  • The critical question is whether 183 ng/mL exceeds the upper limit of the age-specific reference range used by your laboratory 1

If Truly Elevated: Primary Pathological Cause

Acromegaly (GH-Secreting Pituitary Adenoma)

If IGF-1 is confirmed elevated for age, acromegaly is the most important diagnosis to exclude due to its significant impact on cardiovascular mortality and morbidity 1.

Clinical features to assess:

  • Acral enlargement (enlarged hands, feet, shoe/glove/ring size changes) 1
  • Coarsened facial features, frontal bossing, prognathism 1
  • Headaches or visual field defects 1
  • Diabetes mellitus or glucose intolerance 1
  • Hypertension 1
  • Joint pain, carpal tunnel syndrome 1

Diagnostic workup:

  • Measure serum growth hormone level - if GH ≥1 ng/mL, proceed with oral glucose tolerance test 1
  • Oral glucose suppression test: failure to suppress GH below 1 ng/mL (or <0.4 ng/mL with sensitive assays) after glucose load confirms GH excess 1
  • Pituitary MRI to identify adenoma 1

Conditions That Can Falsely Elevate IGF-1

Without True GH Excess

Poorly controlled diabetes mellitus can cause falsely elevated IGF-1 levels without actual GH excess 1.

Hepatic or renal failure may produce spuriously elevated IGF-1 measurements 1.

Assay-Related Issues

  • Inter-assay variability is substantial for IGF-1 measurements, requiring use of laboratory-specific reference ranges 1
  • Pre-analytical factors can affect results 2

Conditions That Lower IGF-1 (Making 183 ng/mL Less Concerning)

If the patient has any of these conditions, an IGF-1 of 183 ng/mL is even more likely to be normal or relatively elevated:

  • Severe hypothyroidism suppresses IGF-1 generation 1
  • Malnutrition or low energy states decrease IGF-1 while potentially increasing GH (GH resistance) 1, 3, 4
  • Severe infection or critical illness can uncouple GH and IGF-1 4
  • Oral estrogen use reduces hepatic IGF-1 generation 1

Critical Pitfall to Avoid

Do not diagnose acromegaly based on IGF-1 alone without confirming GH elevation 2, 5. While elevated IGF-1 is sufficient to establish acromegaly diagnosis in most cases with clear clinical features, modest IGF-1 elevation (less than twice the upper limit of normal) requires corroborative evidence from GH testing 5.

Recommended Diagnostic Algorithm

  1. Verify the IGF-1 is truly elevated by comparing to the specific upper limit of normal for age 71 and female sex in your laboratory's reference range 1

  2. If elevated: Measure random serum GH level 1

  3. If GH ≥1 ng/mL: Perform oral glucose tolerance test with GH measurements 1

  4. If GH fails to suppress <1 ng/mL: Order pituitary MRI and refer to endocrinology 1

  5. Assess for confounding factors: Check thyroid function, nutritional status, diabetes control, renal and hepatic function, and medication history (especially oral estrogens) 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Biochemical discrepancies in the evaluation of the somatotroph axis: Elevated GH or IGF-1 levels do not always diagnose acromegaly.

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 2022

Guideline

Hormonal Changes Due to Poor Nutrition

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormone.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.